X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

January 10, 2020

West Educational Series: The Impact of Yesterday’s Packaging on Today’s Drugs and Tomorrow’s Applications

Containment/delivery systems for sensitive biologic drugs must provide the chemical, physical, and performance properties required to ensure product quality through shelf life. Further, they must be compatible with fill/finish operations, and enable functional performance during administration. Legacy rubber components may no longer meet the increasing technical and regulatory requirements of current and future biologic drug products.
Bjoern Henze

Bjoern Henze, Ph.D.

Manager, TCS, Commercial EU

Previous Posts
Flex Fillers

July 18, 2019

Flexible Fillers: What’s All the Hype?

Simon Cote

Simon Cote

Director, Technical Accts, TCS, NA

SmartDose In-Use

May 07, 2019

The Impact Poor Formulations Have on Drug Development Programs

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Introducing Integrated Solutions

May 02, 2019

FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Stoppers

April 23, 2019

Selecting the Right Package for a Drug Product

Page McAndrew

T. Page McAndrew

Director, Scientific Communications

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Ready Pack System

March 12, 2019

Molecule to Market – Simplify the Journey™ for New Drug Products

Cathy Chhour

Cathy Chhour

Sr. Technical Account Specialist, TCS

Load more